v3.22.4
Balance Sheet Details - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Condensed Financial Statements, Captions [Line Items]      
Term of debt instrument 12 months 12 months  
Current available-for-sale securities $ 1,810,000,000 $ 1,360,000,000  
Noncurrent available-for-sale securities   320,700,000  
Realized gain (loss) on available for sale securities 0 0 $ 0
Unrealized gain (loss) 0 0 0
Income from equity investments 200,000 11,600,000 [1] 0 [1]
Cash discounts reserve 8,300,000 13,700,000 15,900,000
Depreciation expense 144,100,000 96,300,000 64,000,000.0
Loss on disposal of machinery and equipment 2,200,000 24,500,000 13,600,000
Other assets 47,100,000 $ 10,500,000 [2]  
Maximum      
Condensed Financial Statements, Captions [Line Items]      
Term of debt instrument   18 months  
Receiver Product Component      
Condensed Financial Statements, Captions [Line Items]      
Inventory write-down $ 13,900,000 $ 28,100,000 $ 24,400,000
[1] * We adjusted our 2021 and 2020 amounts to reflect the simplified convertible instruments accounting guidance, which we adopted on a full retrospective basis. All periods presented have also been adjusted to reflect the four-for-one stock split. Refer to Note 1, “Organization and Significant Accounting Policies,” to the consolidated financial statements for further information.
[2] * We adjusted our 2021 amounts to reflect the simplified convertible instruments accounting guidance, which we adopted on a full retrospective basis. All periods presented have also been adjusted to reflect the four-for-one stock split. Refer to Note 1, “Organization and Significant Accounting Policies,” to the consolidated financial statements for further information.